Background: Available methods for the determination of nanomolar concentrations of S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) in plasma and cerebrospinal fluid (CSF) are time-consuming. We wished to develop a method for their rapid and simultaneous measurement. Methods: We used tandem mass spectrometry (MS/MS) for the simultaneous determination of SAM and SAH, with stable-isotope-labeled internal standards. The 13 C 5 -SAH internal standard was enzymatically prepared using SAH-hydrolase and [ 13 C 5 ]adenosine. The method comprises a weak anion-exchange solid-phase extraction procedure serving as clean-up step for the deproteinized plasma and CSF samples. After clean-up, samples were injected on a C 18 HPLC column, which was connected directly to the tandem mass spectrometer, operating in MS/MS mode. Results: In plasma samples, the intraassay CVs for SAM and SAH were 4.2% and 4.0%, respectively, and the interassay CVs were 7.6% and 5.9%, respectively. In CSF, the intraassay CVs for SAM and SAH were 6.8% and 6.9%, respectively, and the interassay CVs were 4.2% and 5.5%, respectively. Mean recovery of SAM and SAH for both matrices at two concentrations was 93%. Detection limits for SAM and SAH in samples were 7.5 and 2.5 nmol/L, respectively. Concentrations of SAM and SAH in plasma from healthy subjects were within the previously reported ranges. In 10 CSF samples, the mean concentrations (range) were 248 (137-385) nmol/L for SAM and 11.3 (8.9 -14.1) nmol/L for SAH. Conclusions: SAM and SAH can be analyzed by MS/ MS, taking optimal advantage of the speed and high
maintenance of myelin. Patients with significant demyelination, as observed by magnetic resonance imaging, showed complete reversion of the magnetic resonance imaging alterations after oral treatment with SAM (5 ) . Because the interest in plasma and CSF concentrations of SAM and SAH derives from a broad spectrum of research, a fast, sensitive, and precise analytical method for the determination of these important intermediates is required.
Many methods have been designed for the determination of SAM and SAH in body fluids and tissues. Because the concentrations of SAM and SAH in tissue, red blood cells, and lymphocytes are in the micromolar range, HPLC combined with ultraviolet detection is frequently used for these matrices (6 -9 ) . In plasma and CSF, however, the concentrations of SAM and SAH are considerably lower, requiring more sensitive detection. A sensitive HPLC method has been described that is based on the conversion of SAM and SAH to their 6-etheno analogs, highly fluorescent derivatives that enable detection in the nanomolar range (10, 11 ) . More recently, an alternative for this fluorescence method was described in which SAM and SAH were converted to isoindoles by derivatization with naphthalenedialdehyde and cyanide (12 ) . Both fluorescence methods showed adequate sensitivity but had the disadvantage of being very laborious and time-consuming. In this perspective, the method published by Melnyk et al. (13 ) was a major step forward. In this method, SAM and SAH are measured in trichloroacetate extracts of plasma, tissue, and lymphocytes, using electrochemical detection of nonderivatized SAM and SAH. Although the total analysis time was relatively short, only 20 samples could be processed in 1 day.
Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) is a relatively new analytical technique that is establishing itself because of its high selectivity, sensitivity, and sample throughput. Magera et al. (14 ) showed that LC-MS/MS is a powerful analytical tool for rapid and sensitive determination of total homocysteine in plasma and urine. The possibility of using stable-isotope-labeled internal standards is an additional advantage of LC-MS/MS. In this report, we describe a fast and precise stable-isotope dilution LC-MS/MS method for the combined quantification of SAM and SAH in plasma and CSF samples. sample preparation Plasma or CSF aliquots of 500 L were deproteinized by the addition of 312 L of 100 mL/L perchloric acid. The mixture was mixed thoroughly and then centrifuged for 10 min at 2000g at 4°C. From the clear supernatant, 500 L was transferred to a second test tube, and 50 L of internal standard mixture containing 0.50 mol/L 13 C 5 -SAH and 1.0 mol/L 2 H 3 -SAM was added. The solution was neutralized by the addition of 140 L of 1 mol/L phosphate buffer (pH 11.5) after which 1 mL of H 2 O was added. The solution was applied to an OASIS solid-phase extraction (SPE) column (60 mg, 3 mL; Waters), which was conditioned with 1 mL of methanol, 750 L of 10 mmol/L lauric acid in 0.1 mol/L NaOH, and 1 mL of H 2 O. After the sample had passed through the column by gravity, the column was rinsed with 700 L of H 2 O. Analytes were eluted from the column with 800 L of H 2 O-methanol (85:15, by volume), containing 1 mL/L formic acid. Calibrators (included in each batch of sam-ples) at concentrations of 0, 10, 25, 50, and 100 nmol/L for SAH and 0, 20, 50, 100, and 200 nmol/L for SAM were prepared in 40 mL/L perchloric acid. To 500 L of calibration solution was added 50 L of internal standard mixture, followed by 225 L of 1 mol/L phosphate buffer (pH 11.5) and 1 mL of H 2 O. Calibrators were then processed as described above. The concentration of the analyte in plasma or CSF was calculated by interpolation of the observed analyte/internal standard peak-area ratio into the linear regression line for the calibration curve, which was obtained by plotting the peak-area ratios vs analyte concentration.
Materials and Methods materials

methods
All analyses were performed on an API 3000 triple quadrupole tandem mass spectrometer (PE-Biosystems Sciex). Side instrumentation consisted of a Perkin-Elmer Series 200 HPLC pump, a Perkin-Elmer Series 200 autosampler, and a Harvard Apparatus Pump 11 infusion pump. Liquid chromatography was performed on a Symmetry C 18 analytical column (2.1 ϫ 100 mm; 3.5 m bead size; Waters) using H 2 O-methanol (85:15, by volume) containing 0.2 mL/L butyric acid, pH 4.5, as mobile phase at a flow rate of 175 L/min. The column was connected directly to the turbo ion electrospray operating in the positive-ion mode. The temperature of the turbo ion electrospray was set at 400°C, turbo ion gas (nitrogen) was used at a flow rate of 8 L/min, and the ion spray voltage was 6000 V. The mass spectrometric system was automatically optimized by constant infusion at a flow rate of 5 L/min of a 20 mol/L calibration solution in mobile phase. This optimization included collision-activated decomposition MS/MS, which was performed in the second quadrupole using nitrogen at 0.06 kPa as collision gas. Quadrupole 1 and quadrupole 3 were calibrated monthly by direct infusion at 10 L/min of a 0.1 mmol/L polypropyleneglycol solution. Data were acquired and processed using Analyst for Windows NT software (Ver. 1.0). 
Results
mass spectra
Collisional activated decomposition MS/MS spectra of 2 H 3 -SAM, SAM, 13 C 5 -SAH, and SAH are shown in Fig. 1 . Fragment m/z 136 was found in all MS/MS spectra. In the MS/MS spectra of both 13 C 5 -SAH and SAH, an additional fragment of m/z 133.9 was found, which most likely derives from the homocysteine part of the molecule. To investigate the origin of the m/z 136 fragment, we obtained MS/MS spectra of S-adenosylethionine and Table 1 .
spe
The main function of the SPE procedure was to eliminate perchloric acid and other ionization-suppressing compounds from the plasma and CSF extracts. Perchloric acid strongly interferes with the mass spectrometric measurements, decreasing sensitivity. OASIS extraction columns were loaded with 750 L of 10 mmol/L lauric acid solution, which enabled weak ion extraction. Elution of , which is a compatible solution for the LC-MS/MS analysis. The efficiency of the SPE procedure was examined in an experiment in which six identical pooled plasma samples were used. The samples were split in two groups. The first group consisted of three plasma samples to which the internal standard mixture was added before the SPE procedure. The second group consisted of three plasma samples, and the internal standard mixture was added to the eluate of the SPE procedure. The average of the observed calibrators/internal standard peak-areas ratios in group 2 was divided by the average of the observed calibrators/ internal standard peak-area ratios in group 1. The efficiency found, expressed as the percentage of recovered analyte, was 65% for SAM and 80% for SAH. 
linearity
The calibration curve was linear over concentrations of 10 -100 nmol/L for SAH and 20 -200 nmol/L for SAM (Fig. 3) . In all cases, the coefficient of linear correlation (r 2 ) was Ͼ0.99 for the calibration curves of both SAM and SAH.
limits of detection, precision, and recovery
Limits of detection for SAM and SAH were estimated in samples by verifying the peak height of the analyte and the noise in the chromatographic region of the analyte. The minimal detectable concentrations of the analytes in samples, at a signal-to-noise ratio Ͼ5, were 7.5 and 2.5 nmol/L for SAM and SAH, respectively. The validation data of the presented method are listed in Tables 2 and 3 . All validation experiments were performed with pooled plasma and pooled CSF samples. The interassay and intraassay CVs (n ϭ 10) for SAM and SAH in both matrices were Ͻ8%. Recovery experiments were performed at two different concentrations. Mean recoveries (n ϭ 5) for SAM and SAH for both matrices were 93% with CVs of 2.7-5.0%.
values in human samples
In 15 plasma samples from premenopausal women with normal plasma homocysteine, the mean SAM concentra- 
Discussion
Interest in the measurement of SAM and SAH in different body fluids and tissues has emerged over the years. This has been especially true since homocysteine was recognized as a risk factor for atherosclerotic diseases. The direct precursor of homocysteine, SAH, is suggested to be an inhibitor of methyl transferases in which SAM functions as methyl donor. In CSF, low SAM concentrations have been found in patients suffering from various metabolic and nonmetabolic disorders. We present a rapid and precise LC-MS/MS method that is capable of handling large numbers of samples. The high selectivity of MS/MS does not require extensive HPLC separation, although it is very important to achieve separation between the analytes of interest and early eluting matrix components. The high sensitivity, attributable to the high selectivity, eliminates the need for derivatization. Additionally, MS/MS analysis allows the use of stable-isotope-labeled internal standards, making the method more accurate and precise. The method comprises a SPE procedure as clean-up step for the perchlorate fractions. Other investigators have used C 18 or OASIS cartridges loaded with heptane sulfonic acid to enhance strong cation-exchange extraction of SAM and SAH (10, 12 ) . This type of extraction requires either a high modifier concentration in the eluting solvent or a displacer cation to elute the analytes, which makes extracts less compatible with MS/MS. Our extraction procedure on OASIS columns, loaded with lauric acid, was carried out at neutral pH. At this pH, the carboxylic group of lauric acid is negatively charged and the amine groups of SAM and SAH are positively charged. SAM and SAH were eluted at low pH, which protonates the carboxylic group of lauric acid and consequently terminates the electrostatic interaction between the analytes and the extraction column. The use of OASIS extraction columns loaded with lauric acid enabled elution with a mild solvent at low pH, yielding clean extracts with sufficient extraction efficiency. The use of labeled internal standards corrects for sample-to-sample differences in extraction performances.
No interfering peaks were observed in the MRM mass fragmentograms, which was beneficial to automated processing of the data. The validation data show that the LC-MS/MS method is precise and reliable. Known amounts of SAM and SAH that were added to plasma and CSF were almost completely recovered. The fully automated method can run without manual assistance: calibrators are processed, and the concentrations of SAM and SAH in samples are calculated by the Analyst software.
The total analysis time needed for 20 samples is Ͻ2.5 h: 1-1.5 h of sample preparation time plus 1 h of LC-MS/MS measuring time. This opens perspectives for large-scale SAM and SAH measurements in clinical studies of the pathophysiology of homocysteine metabolism. In addition, CSF samples from children and adults with neurological disturbances can be screened for SAM and SAH to gain more insight into the roles of these analytes. In Table  4 , the SAM and SAH values described here are compared with values reported by others. In the literature, there is consensus of the plasma concentrations of SAH with our data for premenopausal women at the upper end of the range of reported values. For plasma SAM, however, a wide range of values [60 -156 nmol/L; Refs. (11 ) and (13 ), respectively] has been reported. An explanation might be technical problems inherent to the HPLC methods used. Other groups, as well as our laboratory, have encountered difficulties in chromatographic separation and detection with available HPLC methods. The resulting coelution of interfering compounds is likely to produce systematic overestimation of SAM in plasma samples. This problem can explain the high plasma SAM concentrations in some reported studies (12, 13 ) . The use of the LC-MS/MS method overcomes this systematic bias because stableisotope-labeled internal standards were used and interferences by other compounds were absent.
The possibility of measuring isotopically enriched SAM and SAH with minimal sample size might be very useful for researchers using stable-isotope tracer techniques, e.g., [ 2 H 3 ]methyl-[1-13 C]methionine (15 ) or [1-
13 C]homocysteine (16 ) , to study in vivo and in vitro cellular metabolism of methionine, homocysteine, and related compounds involved in 1-carbon metabolism. Precise and accurate isotopic enrichments and concentrations of SAM and SAH can now be measured using this fast online method.
